Cargando…
Anti-RhD antibody therapy modulates human natural killer cell function
Anti-RhD antibodies are widely used in clinical practice to prevent immunization against RhD, principally in hemolytic disease of the fetus and newborn. Intriguingly, this disease is induced by production of the very same antibodies when an RhD negative woman is pregnant with an RhD positive fetus....
Autores principales: | Elias, Shlomo, Kol, Inbal, Kahlon, Shira, Amore, Rajaa, Zeibak, Mariam, Mevorach, Dror, Elchalal, Uriel, Zelig, Orly, Mandelboim, Ofer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252960/ https://www.ncbi.nlm.nih.gov/pubmed/32467141 http://dx.doi.org/10.3324/haematol.2019.238097 |
Ejemplares similares
-
Obinutuzumab activates FcγRI more potently than other anti-CD20 antibodies in chronic lymphocytic leukemia (CLL)
por: Elias, Shlomo, et al.
Publicado: (2018) -
RHD genotyping to resolve weak and discrepant RhD patient phenotypes
por: Barriteau, Christina M., et al.
Publicado: (2022) -
Single-strained DNA aptamers mask RhD antigenic epitopes on human RhD(+) red blood cells to escape alloanti-RhD immunological recognition
por: Zhang, Yinze, et al.
Publicado: (2020) -
RhD Specific Antibodies Are Not Detectable in HLA-DRB1(*)1501 Mice Challenged with Human RhD Positive Erythrocytes
por: Bernardo, Lidice, et al.
Publicado: (2014) -
The Significance of RHD Genotyping and Characteristic Analysis in Chinese RhD Variant Individuals
por: Ying, Yanling, et al.
Publicado: (2021)